Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

1.44
Delayed Data
As of 3:59pm ET
 -0.07 / -4.64%
Today’s Change
0.61
Today|||52-Week Range
3.50
+71.39%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues164.8M19.3M1.3M18.1M
 
 
 
 
 
Depreciation And Amortization1.7M2.5M3.8M6.2M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses129.2M125.8M93.4M50.6M
 
 
 
 
 
Research And Development101.7M91.4M68.5M38.3M
 
 
 
 
 
Total Operating Expenses130.9M128.3M97.2M56.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income33.9M-109.0M-95.9M-38.7M
 
 
 
 
 
Extraordinary Charge0.00-2.6M-8.1M-11.7M
 
 
 
 
Interest Expense On Debt3.8M3.5M3.1M2.4M
 
 
 
 
 
Other Expenses10.0K247.0K-23.0K66.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income30.6M-114.4M-107.0M-52.7M
 
 
 
 
 
Net Income30.6M-114.4M-107.0M-52.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS39.7M43.4M50.9M52.3M
 
 
 
 
 
Shares To Calculate EPS Diluted41.5M43.4M50.9M52.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.74-$2.64-$2.10-$1.01
 
 
 
 
 
EPS Diluted$0.74-$2.64-$2.10-$1.01